Loading the session
Loading the session
Loading instrument
$34.09
+6.03%Market closedDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:28 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
1 month: +16.3% (SPY −1.6%). 3 months: +30.7% (SPY −0.4%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: LKFT, SPY · as of 4 Nov 2026
The 4 Nov 2026 gain of 6.0% was 4.3× its average daily move of 1.4% over the prior 123 sessions, and its largest one-day gain since 11 Aug 2026.
Daily closes, split-adjusted · as of 4 Nov 2026
The 14-session relative strength index closed at 77.3 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026
The 4 Nov 2026 close of $34.09 was 14.8% above its 50-day average ($29.70).
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
4 Nov 2026 volume of 447.2K shares was 1.6× the average of the 30 sessions before it (273.4K), as the price rose 6.0%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
November 4, 2026
+6.03%September 17, 2026
+5.01%August 11, 2026
+6.76%